Año 2018 / Volumen 110 / Número 7
Original
EUS-FNA cytological material from pancreatic lesions: the expression of cathepsins and its predictive value of malignancy

446-450

DOI: 10.17235/reed.2018.4200/2016

Manuela Roger, Juan Martínez, Gloria Peiró, Jose Ramón Aparicio, Francisco Ruiz, Luís Compañy, Juan Antonio Casellas,

Resumen
Aims: To assess the expression of cathepsins in pancreatic samples obtained by endoscopic ultrasonography and fine needle aspiration (EUS-FNA) and to investigate their relationship with the staging of the pancreatic ductal adenocarcinoma (PDAC). Methods: We prospectively included patients with solid pancreatic masses, in which EUS-FNA were performed. Cathepsins B, L, S and H expression was determined in FNA samples. Results: Seventeen FNA were performed. All cytological material was from PDAC. Expression of cathepsins was predominantly low (B 65%, L 23%, S 76%, and H 41%). We found no correlation between the expression levels and the extension of the neoplasm. Conclusion: Expression of cathepsins in the cytological material of PDAC is diverse but still poor to be useful in the pre-operative diagnosis. There is no correlation between the expression levels of cathepsins and the extension of the PDAC
Share Button
Nuevo comentario
Comentarios
No hay comentarios para este artículo.
Bibliografía
1.- Ryan DP, Hong TS, Bardeesy N. Pancreatic adenocarcinoma. New Engl J Med 2014; 371: 1039-1049
2.- Garcea G, Neal CP, Pattender CJ, Steward WP, Berry DP. Molecular prognostic markers in pancreatic cancer: a systematic review. Eur J Cancer 2005; 41: 2213-2236
3.- Turk B, Stoka V, Rozman-Pungercar J, Cirman T, Droga-Mazovec G, Oresic K, Turk V. Apoptotic pathways: involvement of lysosomal proteases. Biol Chem 2002; 383: 1035-1044
4.- Gocheva V, Wang HW, gadea BB, Shree T Hunter KE, Garfall AL, Berman T, Joyce JA. Il-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion. Genes Dev 2010; 24: 241-255
5.- Nomura T, Katunuma N. Involvement of cathepsins in the invasion, metastasis and proliferation of cancer cells. J Med Invest 2005; 52: 1-9
6.- Vasiljeva O, Papazoglou A, Kruger A, Brodoefel H, Korovin M, Deussing J, Augustin N, Nielsen BS, Almholt K, Bogyo M, Peters C, Reinheckel T. Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer. Cancer Res 2006; 66: 5242-5250
7.- Aggarwal N, Sloane BF. Cathepsin B: multiple roles in cancer. Proteomics Clin Appl 2014; 8: 427-437
8.- Joyce JA, Hanahan D. Multiple roles for cysteine cathepsins in cancer. Cell Cycle 2004; 3: 1516-1519
9.- Reinheckel T, Peters C, Krüger A, Turk B, Vasiljeva O. Differential impact of cysteine cathepsins on genetic mouse models of the novo carcinogenesis: cathepsin B as emerging therapeutic target. Front Pharmacol 2012; 3: 133
10.- Sulpizio S, Franceschini N, Piatelli A, Di Sebastiano P, Innocenti P, Selvaggi F. Cathepsins and pancreatic cancer: the 2012 update. Pancreatology 2012; 12: 395-401
11.- Hwang JH; Lee SH, Lee KH, Kim H, Ryu JK, Yoon YB, Kim YT. Cathepsin B is a target of hedgehog signaling in pancreatic cancer. Cancer Lett 2009; 273: 266-272
12.- Zhang C, Sun J, Liu D, Cui Y, Liu S, Sun H. Preliminary research on yhe pathological role of cathepsin-B in subcutaneous heteroplastic pancreatic carcinoma in nude mice. Chin Med J 2009; 122: 2489-2496
13.- Gopinathan A, de Nicola G, Frese K, Cook N, Karreth FA, Mayerle J, Lerch MM, Reincheckel T, Tuveson DA. Cathepsin B promotes the progression of pancreatic ductal carcinoma in mice. Gut 2012;61:877-884
14,- Von Burstin J, Eser S, Seidler B, Meining A, Bajbouj M, Mages J, Lang R, Kind A, Schnieke A, Schmid R, Schneider G, Saur D. Highly sensitive detection of early-stage pancreatic cancer by multimodal near-infrared molecular imaging in living mice. Int J Cancer 2008; 123: 2138-2147
15.- Leto G, Tumminello FM, Pizzolanti G, Montalvo G, Zorreéis M, Carroccio A, Hipólito S, Gebbia N. Lysosomal aspartic and cysteine proteinases serum levels in patients with pancreatic cancer or pancreatitis. Pancreas 1997; 14: 22-27
16.- Azuma T, Hirai M, Ito S, Yamamoto K, Taggart RT, Matsuba T, Yasukawa K, Uno K, Hayakumo T, Nakajima M. Expression of cathepsin E in pancreas: a possible tumor marker for pancreas, a preliminary report. Int J Cancer 1996; 67: 492-497
17.- Cruz-Monserrate Z, Abd-Elgaliel W, Grote T, Deng D, Ji B, Arumugam T, Wang H, Tung C, Logsdon C. Detection of pancreatic tumours and precursor lesions by cathepsin E activity in mouse models. Gut 2012; 61; 1315-1322
18. - Eser S, Messer M, Eser P, von Werder A, Seidler B, Bajbouj M, Vogelman R, Meining A, von Brurstin, Algül, Pagel P, Schinieke AE, Esposito I, Schmid RM, Schneider G, Saur D. in vivo diagnosis of murine pancreatic intraepithelial neoplasia and early-stage pancreatic cancer by molecular imaging. PNAS 2011; 108: 9945-9950
19.- UICC TNM Classification Edition 7 published 2009 and went into effect 2010
20.- Niedergethmann M, Wostbrock B, Sturm JW, Willeke F, Post S, Hildenbrand R. Pancreatic impact of cysteine proteases cathepsin B and cathepsin L in pancreatic adenocarcinoma. Pancreas 2004; 29: 204-211
21.- Niedergethmann M; Hildenbrand R, Wolf G, Verbeke CS, Richter A, Post S. Angiogenesis and cathepsin exxpression are prognostic factors in pancreatic adenocarcinoma after curative resection. Int J Pancreatol 2000; 28: 31-39
22.- Ohta T, Terada T, Nagakawa T, Tajima H, Itoh H, Fonseca L, Miyazaki I. Pancreatic trypsinogen and cathepsin B in human pancreatic carcinomas and associated metastasic lesions. Br J Cancer 1994; 69: 152-156
23.- Gocheva V, Wang HW, Gadea BB, Shree T Hunter KE, Garfall AL, Berman T, Joyce JA. Il-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion. Genes Dev 2010; 24: 241-255
24.- Joyce JA, Baruch A, Chehade K, Meyer-Morse N, Giraudo E, Fong-Ying Tsai, Greenbaum DC, Hager JH, Bogyo M, Hanahan D. Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. Cancer Cell 2004; 5: 443-453
25.- Gocheva V, Chen X, Peters C, Reinheckel T. Joyce J. Deletion of cathepsin H perturbs angiogenic switching, vascularization and growth of tumors in a mouse model of pancreatic islet cell cancer. Biol Chem 2010; 391: 937-945
Artículos relacionados

Carta

Gastric schwannoma diagnosing gastric stromal tumor

DOI: 10.17235/reed.2023.9919/2023

Imagen en Patología Digestiva

Lesión metastásica en cabeza pancreática secundaria a melanoma de coroides

DOI: 10.17235/reed.2022.8843/2022

Carta

Mucinous cystadenoma arising from a pancreatic heterotopia

DOI: 10.17235/reed.2020.7486/2020

Carta al Editor

Tumores neuroendocrinos pancreáticos

DOI: 10.17235/reed.2017.4725/2016

Original

3D echoendoscopy and miniprobes for rectal cancer staging

DOI: 10.17235/reed.2018.4453/2016

Instrucciones para citar
Roger M, Martínez J, Peiró G, Aparicio J, Ruiz F, Compañy L, et all. EUS-FNA cytological material from pancreatic lesions: the expression of cathepsins and its predictive value of malignancy. 4200/2016


Descargar en un gestor de citas

Descargue la cita de este artículo haciendo clic en uno de los siguientes gestores de citas:

Métrica
Este artículo ha sido visitado 715 veces.
Este artículo ha sido descargado 80 veces.

Estadísticas de Dimensions


Estadísticas de Plum Analytics

Ficha Técnica

Recibido: 11/01/2016

Aceptado: 11/02/2018

Prepublicado: 12/06/2018

Publicado: 02/07/2018

Tiempo de revisión del artículo: 729 días

Tiempo de prepublicación: 883 días

Tiempo de edición del artículo: 903 días


Compartir
Este artículo aun no tiene valoraciones.
Valoración del lector:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
La REED es el órgano oficial de la Sociedad Española de Patología Digestiva, la SociedadEspañola de Endoscopia Digestiva y la Asociación Española de Ecografía Digestiva
Política de cookies Política de Privacidad Aviso Legal © Copyright 2023 y Creative Commons. Revista Española de Enfermedades Digestivas